ArticleThe Journal of antimicrobial chemotherapy2025
Multidrug efflux pumps and innate azole resistance of Mucor lusitanicus.
Article in The Journal of antimicrobial chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The molecular basis of intrinsic resistance to azoles inAntimicrobial agents and chemotherapy · 2026Article
- Functional characterization ofFrontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesThis study aims to characterize the possible contribution of eight pleiotropic drug resistance (PDR) transporters to the azole resistance phenotype of Mucor lusitanicus.
methodsGene expression analysis (RNA-sequencing and RT-qPCR) was performed on M. lusitanicus CBS277.49 cells exposed to three different types of azoles (4.0 mg/L). C-terminally GFP-tagged M. lusitanicus PDR transporters were overexpressed in the hypersensitive model host, Saccharomyces cerevisiae ADΔΔ. Their efflux pump functions were evaluated by determining the azole susceptibilities of the PDR transporter overexpressing cells and measuring their plasma membrane ATPase activities.
resultsM. lusitanicus PDR transporters separated into two phylogenetic clusters: A (pdr1, pdr6-8) and B (pdr2-5). RNA-sequencing and RT-qPCR revealed strong up-regulation of pdr1 and pdr6, but down-regulation of pdr7 and pdr8 in response to 80 min exposures of 4.0 mg/L voriconazole, isavuconazole or posaconazole. The expression of Pdr6 and Pdr7 in S. cerevisiae ADΔΔ increased its resistance to short- and mid-length tailed azoles. Pdr1 and Pdr8 expression, however, conferred pan-azole resistance including long-tailed azoles such as itraconazole and posaconazole. No efflux pump function and ATPase activity were detected for Pdr3 and Pdr5. The ATPase activities of Pdr1, Pdr6, Pdr7 and Pdr8 were comparable to Candida albicans Cdr1 expressed in ADΔΔ.
conclusionsAll Mucor cluster A PDR transporters are multidrug efflux pumps, but Pdr1 and Pdr6 are possibly the major contributors to the innate azole resistance phenotype of M. lusitanicus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.